Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys

Metabolism: Clinical and Experimental

Volumn 46, Issue 6, 1997, Pages 698-705

  Wagner, Janice D ^a   Cefalu, William T ^a   Anthony, Mary S ^a   Litwak, Kenneth N ^a   Zhang, Li ^a   Clarkson, Thomas B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; ESTRADIOL; ESTROGEN; LACTALBUMIN; SOYBEAN PROTEIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; ISCHEMIC HEART DISEASE; MACACA; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; RISK MANAGEMENT;

EID: 0030913204     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90016-0     Document Type: Article

References (55)

1. Beaglehole R: International trends in coronary heart disease mortality, morbidity, and risk factors. Epidemiol Rev 12:1-15, 1990
2. Meeker DR, Kesten HD: Effect of high protein diets on experimental atherosclerosis of rabbits. Arch Pathol 31:147-162, 1941
3. Forsythe WA, Green MS, Anderson JJB: Dietary protein effects on cholesterol and lipoprotein concentrations: A review. J Am Coll Nutr 5:533-549, 1986
4. Potter SM: Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125:6068-611S, 1995 (suppl)
5. Anthony MS, Clarkson TB, Hughes CL, et al: Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126:43-50, 1996
6. Eldridge AC: Determination of isoflavones in soybean flours, protein concentrates, and isolates. J Agricult Food Chem 30:353-355, 1982
7. Setchell KDR: Naturally occurring non-steroidal estrogens of dietary origin, in McLachlan JA (ed): Estrogens in the Environment II. Influences on Development. New York, NY, Elsevier, 1985, pp 69-85
8. Akiyama T, Ishida J, Nakagawa S, et al: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595, 1987
9. Hill TD, Dean NM, Moardan LJ, et al: PDGF-induced activation of phospholipase C is not required for induction of DNA synthesis. Science 248:1660-1663, 1990
10. Barrett-Connor E, Bush TL: Estrogen and coronary heart disease in women. JAMA 265:1861-1867, 1991
11. Adams MR, Kaplan JR, Manuck SB, et al: Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 10:1051-1057, 1990
12. Allain CC, Poon LS, Chan CSG, et al: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974
13. Lipid Research Clinics Program: Manual of Laboratory Operations, vol 1. Lipid and Lipoprotein Analysis. Revised 1982. DHEW Publication No. 75-628. Bethesda, MD, National Heart, Lung, and Blood Institute, National Institutes of Health, 1974
14. Fossati P, Principe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080, 1982
15. Carroll RM, Rudel LL: Lipoprotein separation and low density lipoprotein molecular weight determination using high performance gel-filtration chromatography. J Lipid Res 24:200-207, 1983
16. Cefalu WT, Wagner JD, Bell-Farrow AD, et al: The effects of hormonal replacement therapy on insulin sensitivity in surgically postmenopausal cynomolgus monkeys (Macaco fascicularis). Am J Obstet Gynecol 171:440-445, 1994
17. Cefalu WT, Wang ZQ, Werbel SS, et al: Contribution of visceral fat mass to the insulin resistance of aging. Metabolism 44:954-959, 1995
18. Wagner JD, Martino MA, Jayo MJ, et al: The effects of hormone replacement therapy on carbohydrate metabolism and cardiovascular risk factors in surgically postmenopausal cynomolgus monkeys. Metabolism 45:1254-1262, 1996
19. Jayo JM, Shively CA, Kaplan JR, et al: Effects of exercise and stress on body fat distribution in male cynomolgus monkeys. Int J Obes 15:213-220, 1993
20. Folch J, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957
21. Carr TP, Andresen CJ, Rudel LL: Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26:39-42, 1993
22. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358, 1979
23. Wagner JD, Zhang L, Williams JK, et al: Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys. Arterioscler Thromb Vasc Biol 16:1473-1480, 1996
24. Adams MR, Register TC, Golden DL, et al: Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 17:217-221, 1997
25. Manning JM, Campos G, Edwards IJ, et al: Effects of hormone replacement modalities on low density lipoprotein composition and distribution in ovariectomized cynomolgus monkeys. Atherosclerosis 121:217-229, 1996
26. van der Mooren MJ, de Graaf J, Demacker PN, et al: Changes in the low-density lipoprotein profile during 17β-estradiol-dydrogesterone therapy in postmenopausal women. Metabolism 43:799-802, 1994
27. Campos H, Sacks FM, Walsh BW, et al: Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism 42:1153-1158, 1993
28. Sirtori CR, Galli G, Lovati MR, et al: Effects of dietary proteins on the regulation of liver lipoprotein receptors in rats. J Nutr 114:1493-1500, 1984
29. Lovati MR, Manzoni C, Casavesi A, et al: Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 80:1498-1502, 1987
30. Nabulsi AA, Folsom AR, White A, et al: Association of hormone replacement therapy with various cardiovascular risk factors in post-menopausal women. N Engl J Med 328:1069-1075, 1993
31. Barrett-Connor E, Laakso M: Ischemic heart disease risk in post-menopausal women. Effects of estrogen use on glucose and insulin levels. Arteriosclerosis 10:531-534, 1990
32. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199-208, 1995
33. Lindheim SR, Presser SC, Ditkoff EC: A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 60:664-667, 1993
34. Lindheim SR, Duffy DM, Kojima TK, et al: The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil Steril 62:1176-1180, 1994
35. Kumagai S, Holmang A, Bjorntorp P: The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 149:91-97, 1993
36. Godsland IF, Gangar K, Walton C, et al: Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 42:846-853, 1993
37. Notelovitz M: Carbohydrate metabolism in relation to hormonal replacement therapy. Acta Obstet Gynecol Scand Suppl 106:51-56, 1982
38. Sorenson RL, Brelje TC, Roth C: Effect of tyrosine kinase inhibitors on islets of Langerhans: Evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 134:1975-1978, 1994
39. Jonas JC, Plant TD, Gilon P, et al: Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. Br J Pharmacol 114:872-880, 1995
40. Abler A, Smith JA, Randazzo PA, et al: Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. J Biol Chem 267:3946-3951, 1992
41. Costrini NV, Kalkhoff RK: Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion. J Clin Invest 50:992-999, 1971
42. White MF, Kahn CR: The insulin signaling system. J Biol Chem 269:1-5, 1994
43. Ebina Y, Araki E, Taira M, et al: Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci USA 84:704-708, 1987
44. r.185,000 protein in intact cells. Nature 318:183-186, 1985
45. Sun XJ, Rothenberg PL, Kahn CR, et al: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77, 1991
46. Stern MP, Haffner SM: Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 6:123-130, 1986
47. Wade GN: Gonadal hormones and behavioral regulation of body weight. Physiol Behav 8:523-534, 1972
48. Haarbo J, Marslew U, Gotfredsen A, et al: Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40:1323-1326, 1991
49. Arjmandi BH, Alekel L, Hollis BW, et al: Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161-167, 1996
50. Subbiah MTR, Kessel B, Agrawal M, et al: Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 77:1095-1097, 1993
51. Huber LA, Scheffler E, Poll T, et al: 17 Beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Radic Res Commun 8:167-173, 1990
52. Kanazawa T, Osanai T, Zhang XS, et al: Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular diseases. J Nutr 125:639S-646S, 1995 (suppl)
53. Wei H, Wei L, Frenkel K, et al: Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20:1-12, 1993
54. Rifici VA, Schneider SH, Khachadurian AK: Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I. Atherosclerosis 107:99-108, 1994
55. St. Clair RW: Atherosclerosis regression in animal models: Current concepts of cellular and biochemical mechanisms. Prog Cardiovasc Dis 26:109-132, 1983